Will Negative-Beta Stocks Help Outperform the TSX?

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has seen returns of over 4% year to date, while the TSX has seen losses.

| More on:

Beta is a measure of risk; specifically, it’s how risky a stock is in relation to the market. A beta of more than one indicates a stock has larger swings than the market, and a beta of less than one indicates it has less volatile swings. A negative beta, however, suggests that the stock moves in the opposite direction of the index. Beta can change over time, and one financial website can calculate beta over a different period of time than another website. It can be a moving target, so it is important to understand why there might be fluctuations or differences in it.

Alimentation Couche Tard Inc. (TSX:ATD.B) has a beta of -0.36, and year-to-date returns have been down over 2%, while the TSX has returned a loss of 0.90%. If we look at a broader range, 12 months, then Couche Tard has a positive return of 1%, but it is still less than the almost 4% the TSX has brought in. We need to look at the five-year window before we see the stock outperform the TSX, with its return climbing to 277% compared to just 28% for the market.

In the short term, Couche Tard has not provided investors with much security over the TSX and has actually performed worse. In the long term, the stock’s performance has been due in large part to its successful sales and profit growth over the years, and during that time its beta may have looked much different.

Waste Connections Inc. (TSX:WCN)(NYSE:WCN) also has a negative beta of -0.14 listed for its stock. Year to date, this stock has been up over 15% and almost 25% in the past 12 months. In this case, the negative-beta stock has vastly outperformed the TSX. If we extend the outlook to five years, then the gap is even wider, with Waste Connections yielding a total return of over 185%.

Waste Connections is a winner in all time frames and could be a good stock to rely on outperform the TSX.

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) lists a high negative beta of -0.81 and, year to date, has seen returns of just over 4%. However, in the past 12 months, the stock has been much worse than the TSX, losing over 30% in value. In the past five years, the stock has declined by over 50%. The only time frame Valeant has proven to beat the TSX is during the short term.

The problem with this analysis is that Valeant’s stock has seen a significant tumble due to its own doing and internal problems. The recent outperformance of the TSX may have had more to do with the stock reaching a bottom rather than having a tendency to go in the opposite direction of the market.

With the exception of Waste Connections, the stocks here have not proven to be more helpful in beating the TSX, especially in the short term. The one reason Waste Connections may be able to ignore the TSX’s overall impact is because the company is effectively recession-proof; the company’s services are needed regardless of whether the economy is doing well or not.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals. Alimentation Couche Tard is a recommendation of Stock Advisor Canada.

More on Dividend Stocks

hand stacks coins
Dividend Stocks

Canada’s Smart Money Is Piling Into This TSX Leader

An expanding and still growing industry giant is a smart choice for Canadian investors in 2025.

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Dividend Stocks

TFSA Contribution Limit Stays at $7,000 for 2025: What to Buy?

This TFSA strategy can boost yield and reduce risk.

Read more »

Make a choice, path to success, sign
Dividend Stocks

Already a TFSA Millionaire? Watch Out for These CRA Traps

TFSA millionaires are mindful of CRA traps to avoid paying unnecessary taxes and penalties.

Read more »

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Tech Stocks

Best Tech Stocks for Canadian Investors in the New Year

Three tech stocks are the best options for Canadians investing in the high-growth sector.

Read more »

Happy golf player walks the course
Dividend Stocks

Got $7,000? 5 Blue-Chip Stocks to Buy and Hold Forever

These blue-chip stocks are reliable options for investors seeking steady capital gains and attractive returns through dividends.

Read more »

Concept of multiple streams of income
Stocks for Beginners

The Smartest Dividend Stocks to Buy With $500 Right Now

The market is flush with great opportunities right now, and that includes some of the smartest dividend stocks every portfolio…

Read more »

Hourglass projecting a dollar sign as shadow
Dividend Stocks

It’s Time to Buy: 1 Oversold TSX Stock Poised for a Comeback

An oversold TSX stock in a top-performing sector is well-positioned to stage a comeback in 2025.

Read more »

woman looks at iPhone
Dividend Stocks

Where Will BCE Stock Be in 5 Years? 

BCE stock has more than halved in almost three years. Where will the stock be in the next five years?…

Read more »